Literature DB >> 17550345

Resveratrol is a class IA phosphoinositide 3-kinase inhibitor.

Sara Fröjdö1, Delphine Cozzone, Hubert Vidal, Luciano Pirola.   

Abstract

Resveratrol, a polyphenol found in fruits, possesses chemopreventive and chemotherapeutic properties and has been shown to increase lifespan in yeast and metazoans, including mice. Genetic evidence and in vitro enzymatic measurements indicate that the deacetylase Sir2/SIRT1, an enzyme promoting stress resistance and aging, is the target of resveratrol. Similarly, down-regulation of insulin-like pathways, of which PI3K (phosphoinositide 3-kinase) is a key mediator, promotes longevity and is an attractive strategy to fight cancer. We show here that resveratrol inhibits, in vitro and in cultured muscle cell lines, class IA PI3K and its downstream signalling at the same concentration range at which it activates sirtuins. Our observations define class IA PI3K as a target of resveratrol that may contribute to the longevity-promoting and anticancer properties and identify resveratrol as a natural class-specific PI3K inhibitor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550345      PMCID: PMC2049032          DOI: 10.1042/BJ20070236

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

2.  Resveratrol inhibits insulin responses in a SirT1-independent pathway.

Authors:  Jiandi Zhang
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 3.  Therapeutic potential of resveratrol: the in vivo evidence.

Authors:  Joseph A Baur; David A Sinclair
Journal:  Nat Rev Drug Discov       Date:  2006-05-26       Impact factor: 84.694

Review 4.  SIRT1 and endocrine signaling.

Authors:  Tianle Yang; Maofu Fu; Richard Pestell; Anthony A Sauve
Journal:  Trends Endocrinol Metab       Date:  2006-05-08       Impact factor: 12.015

5.  C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span.

Authors:  Ala Berdichevsky; Mohan Viswanathan; H Robert Horvitz; Leonard Guarente
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

6.  Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.

Authors:  Kathryn A Moynihan; Andrew A Grimm; Marie M Plueger; Ernesto Bernal-Mizrachi; Eric Ford; Corentin Cras-Méneur; M Alan Permutt; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2005-08       Impact factor: 27.287

7.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

8.  Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

Authors:  Dario R Valenzano; Eva Terzibasi; Tyrone Genade; Antonino Cattaneo; Luciano Domenici; Alessandro Cellerino
Journal:  Curr Biol       Date:  2006-02-07       Impact factor: 10.834

9.  A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.

Authors:  Zachary A Knight; Beatriz Gonzalez; Morri E Feldman; Eli R Zunder; David D Goldenberg; Olusegun Williams; Robbie Loewith; David Stokoe; Andras Balla; Balazs Toth; Tamas Balla; William A Weiss; Roger L Williams; Kevan M Shokat
Journal:  Cell       Date:  2006-04-27       Impact factor: 41.582

10.  Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells.

Authors:  Laura Bordone; Maria Carla Motta; Frederic Picard; Ashley Robinson; Ulupi S Jhala; Javier Apfeld; Thomas McDonagh; Madeleine Lemieux; Michael McBurney; Akos Szilvasi; Erin J Easlon; Su-Ju Lin; Leonard Guarente
Journal:  PLoS Biol       Date:  2005-12-27       Impact factor: 8.029

View more
  60 in total

1.  Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity.

Authors:  Jinan Wang; Fangfang Wang; Zhengtao Xiao; Guowen Sheng; Yan Li; Yonghua Wang
Journal:  J Mol Model       Date:  2011-12-03       Impact factor: 1.810

2.  The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.

Authors:  Sylvie Casteras; Aya Abdul-Wahed; Maud Soty; Fanny Vulin; Hervé Guillou; Mélanie Campana; Hervé Le Stunff; Luciano Pirola; Fabienne Rajas; Gilles Mithieux; Amandine Gautier-Stein
Journal:  Diabetologia       Date:  2016-09-09       Impact factor: 10.122

3.  Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

Authors:  Balachandar Venkatesan; Anthony J Valente; Venkatapuram Seenu Reddy; Deborah A Siwik; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

4.  Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.

Authors:  Jing Tian; Jin-wei Chen; Jie-sheng Gao; Len Li; Xi Xie
Journal:  Rheumatol Int       Date:  2013-01-18       Impact factor: 2.631

5.  Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation.

Authors:  Urban Svajger; Natasa Obermajer; Matjaz Jeras
Journal:  Immunology       Date:  2009-11-25       Impact factor: 7.397

6.  Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1.

Authors:  Dae Weon Park; Kheewoong Baek; Jae Ryong Kim; Jae Jin Lee; Sang Ho Ryu; Byung Rho Chin; Suk Hwan Baek
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

7.  Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols.

Authors:  Linette Castillo-Pichardo; Michelle M Martínez-Montemayor; Joel E Martínez; Kristin M Wall; Luis A Cubano; Suranganie Dharmawardhane
Journal:  Clin Exp Metastasis       Date:  2009-03-18       Impact factor: 5.150

8.  Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B.

Authors:  Balachandar Venkatesan; Nandini Ghosh-Choudhury; Falguni Das; Lenin Mahimainathan; Amrita Kamat; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

Review 9.  Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases.

Authors:  Jun Ren; Yingmei Zhang
Journal:  Trends Pharmacol Sci       Date:  2018-10-26       Impact factor: 14.819

10.  Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.

Authors:  D Cozzone; S Fröjdö; E Disse; C Debard; M Laville; L Pirola; H Vidal
Journal:  Diabetologia       Date:  2008-01-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.